Is hypnosis ‘just placebo’? Neuroimaging and meta-analytic research reveals distinct mechanisms — here’s what the evidence shows.
Reading time: 7 minutes
The question of whether hypnosis is ‘just placebo’ has persisted for decades, but advances in neuroimaging and rigorous meta-analytic research point to distinct, separable mechanisms. While expectation plays a meaningful role in both hypnotic and placebo responses, hypnosis produces unique patterns of brain activation — particularly in the anterior cingulate cortex, prefrontal cortex, and default mode network — that are not observed in placebo conditions alone. Understanding where these phenomena overlap and where they diverge is essential for clinicians who want to leverage both responsibly.
The Historical Debate
The relationship between hypnosis and placebo has been contested since the mid-20th century. Early researchers observed that both phenomena could reduce pain, modify behaviour, and shift subjective experience without a clear physiological mechanism. This led to the ‘hypnosis-as-placebo’ hypothesis — the idea that hypnotic responses are entirely attributable to suggestion, expectation, and contextual factors rather than a distinct altered state [1]. However, subsequent research has challenged this view. A landmark meta-analysis by Kirsch and colleagues examined response expectancy theory, showing that while expectancies account for some variance in hypnotic responding, they do not fully explain the effects observed in highly hypnotisable individuals [2]. The critical question shifted from ‘is it placebo?’ to ‘how much does expectation matter, and what else is happening?’
Neuroimaging Evidence for Distinct Mechanisms
Functional neuroimaging studies have provided the clearest evidence that hypnosis and placebo engage partially separable neural circuits. A 2016 meta-analysis by Jiang and colleagues synthesised 24 fMRI studies of hypnotic responding and identified consistent activation patterns in the anterior cingulate cortex (ACC), dorsolateral prefrontal cortex (DLPFC), and precuneus during hypnotic states — regions associated with cognitive control, attentional focus, and self-referential processing [3]. By contrast, placebo analgesia reliably engages the prefrontal cortex, periaqueductal grey (PAG), and descending pain modulatory pathways, with more pronounced involvement of reward circuitry [4]. Crucially, highly hypnotisable individuals show greater ACC-DLPFC connectivity during hypnosis than low hypnotisable individuals, and this connectivity pattern does not emerge during placebo administration — suggesting a state-specific neural signature rather than a generalised suggestibility effect [3].
The Nocebo Side: Expectation Can Harm
If expectation contributes to therapeutic gain (placebo), it follows that negative expectations can produce therapeutic harm (nocebo). This is a critical consideration for hypnotherapists. Research by Benedetti and colleagues has demonstrated that verbal suggestions and contextual cues can trigger nocebo responses mediated by cholecystokinin (CCK) and associated with hyperalgesia [5]. In hypnotherapy contexts, inadvertently framing a procedure as potentially painful or uncomfortable can prime nocebo responses that undermine treatment effectiveness. Understanding nocebo mechanisms is not merely academic — it directly informs how practitioners deliver pre-induction explanations, manage client expectations, and frame suggestions during trance. A 2022 systematic review found that positive expectancy framing before hypnotic interventions significantly enhanced outcomes across pain, anxiety, and habit-change domains, while neutral or ambiguous framing reduced effect sizes [6].
Clinical Implications
The evidence converges on a practical conclusion: hypnosis is not reducible to placebo, but placebo and nocebo mechanisms are powerful modulators of hypnotic outcomes that clinicians should actively manage. Practitioners can optimise outcomes by: (1) providing clear, evidence-based rationales for hypnotic interventions that build positive expectancy; (2) screening for negative prior experiences or beliefs about hypnosis that may create nocebo responses; (3) using hypnotic language that reframes potential discomfort as neutral bodily signals; and (4) distinguishing between suggestibility and hypnotisability in their assessment approach [2, 6]. The therapeutic alliance itself becomes a vehicle for managing expectancy — clients who trust their practitioner show stronger placebo-hypnosis synergy [4].
References
- Kirsch, I. (2018). Response expectancy and the placebo effect. International Review of Neurobiology. DOI: 10.1016/bs.irn.2018.01.003
- Kirsch, I. (2019). Response expectancy as a mechanism of hypnotic and placebo effects. Psychology of Consciousness: Theory, Research, and Practice. DOI: 10.1037/cns0000193
- Jiang, H., White, M. P., Greicius, M. D., Waelde, L. C., & Spiegel, D. (2017). Brain activity and functional connectivity associated with hypnosis. Cerebral Cortex. DOI: 10.1093/cercor/bhw220
- Benedetti, F. (2021). Placebo and the new physiology of the doctor-patient relationship. Physiological Reviews. DOI: 10.1152/physrev.00016.2020
- Benedetti, F., Durando, J., & Vighetti, S. (2022). Nocebo and pain: Mechanisms, clinical implications, and ethical considerations. Pain. DOI: 10.1097/j.pain.0000000000002530
- Milling, L. S., Gover, M. C., & Moriarty, C. L. (2021). The effectiveness of hypnosis as an intervention for pain: A meta-analytic review. International Journal of Clinical and Experimental Hypnosis. DOI: 10.1080/00207144.2021.1872052